Lexaria Bioscience (LEXX) Inventory Average (2015 - 2023)
Lexaria Bioscience (LEXX) posted Inventory Average of $8762.0 for Q1 2023, down 63.76% sequentially from $24177.0 in Q4 2022, and down 49.7% YoY from $17420.5 in Q1 2022.
Lexaria Bioscience (LEXX) Inventory Average (2015 - 2023) Analysis & Trends
Lexaria Bioscience has reported Inventory Average for 9 years, with the latest figure at $8762.0 in Q1 2023.
- Quarterly Inventory Average fell 49.7% year-over-year to $8762.0 in Q1 2023, while the trailing twelve-month figure through Feb 2023 was $8762.0 (down 49.7% YoY) and the FY2022 annual result came in at $34033.0, down 53.54% from the prior year.
- Inventory Average declined to $8762.0 in Q1 2023 per LEXX's latest filing, from $24177.0 in the prior quarter.
- Over five years, Inventory Average peaked at $157835.5 in Q3 2019 and troughed at $8762.0 in Q1 2023.
- A 5-year average of $78209.3 and a median of $65607.5 in 2021 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2019 and 2022: Inventory Average jumped 113.16% in 2019, then sank 73.45% in 2022.
- Over 5 years, Inventory Average stood at $130476.0 in 2019, then slumped by 57.54% to $55402.0 in 2020, then plunged by 70.61% to $16281.0 in 2021, then soared by 48.5% to $24177.0 in 2022, then tumbled by 63.76% to $8762.0 in 2023.
- According to Business Quant data, Inventory Average over the past three periods registered $8762.0, $24177.0, and $39300.5 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2023 | 8,762.00 |
| Nov 30, 2022 | 24,177.00 |
| Aug 31, 2022 | 39,300.50 |
| May 31, 2022 | 36,055.00 |
| Feb 28, 2022 | 17,420.50 |
| Nov 30, 2021 | 16,281.00 |
| Aug 31, 2021 | 40,693.00 |
| May 31, 2021 | 94,510.00 |
| Feb 28, 2021 | 65,607.50 |
| Nov 30, 2020 | 55,402.00 |
| Aug 31, 2020 | 124,897.00 |
| May 31, 2020 | 128,667.50 |
| Feb 29, 2020 | 128,984.00 |
| Nov 30, 2019 | 130,476.00 |
| Aug 31, 2019 | 157,835.50 |
| May 31, 2019 | 148,146.50 |
| Feb 28, 2019 | 112,343.00 |
| Nov 30, 2018 | 101,950.50 |
| Aug 31, 2018 | 81,854.00 |
| May 31, 2018 | 69,500.50 |